NCT04673240 - CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 29, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions

SpasticityBrain InjuriesSpinal Cord InjuriesMultiple Sclerosis

Interventions

DRUG

Botulinum toxin type A injection

"Adult patients with spasticity due to traumatic brain injury, spinal cord injury, or MS, treated with Botulinum Toxin type A.~As this is a non-interventional study, no diagnostic, therapeutic, or experimental intervention is involved. Subjects will receive clinical assessments, medications, and treatments solely as determined by their study physician."

Trial Locations (1)

28100

RECRUITING

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara